AFT Pharmaceuticals makes FDA progress

AFT Pharmaceuticals makes FDA progress
Staff reporters
AFT Pharmaceuticals is part way through United States regulatory approvals to get its flagship Maxigesic tablets into that country's market.AFT said the Food and Drug Administration has given it a "complete response letter" saying it has completed its review of Maxigesic, which will be marketed in the US as Combogesic.The FDA requested minor labelling changes and asked for updated global safety data and said the only deficiency was an inspection of the tablet production facilities which has been delayed by covid-19-related travel...